Register entry
SAGE THERAPEUTICS LLC A WHOLLY OWNED SUB OF SUPERNUS PHARMACEUTICALS INC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 8
- Countries
- 0
Exclusivity
Patents and exclusivities
8| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10117951 | ZULRESSObrexanolone | product | Mar 2029 |
| 7635773 | ZULRESSObrexanolone | product | Mar 2029 |
| 8410077 | ZULRESSObrexanolone | product | Mar 2029 |
| 9200088 | ZULRESSObrexanolone | product | Mar 2029 |
| 9750822 | ZULRESSObrexanolone | product | Mar 2029 |
| 10322139 | ZULRESSObrexanolone | product | Jan 2033 |
| 10251894 | ZULRESSObrexanolone | use | Nov 2033 |
| 10940156 | ZULRESSObrexanolone | use | Mar 2037 |
Enquiry
Common questions
- Is SAGE THERAPEUTICS LLC A WHOLLY OWNED SUB OF SUPERNUS PHARMACEUTICALS INC FDA approved?
- SAGE THERAPEUTICS LLC A WHOLLY OWNED SUB OF SUPERNUS PHARMACEUTICALS INC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.